| News & Announcements | New Preventive Coverage of Lenacapavir (Yeztugo) for Pre-exposure Prophylaxis (PrEP) for the Prevention of HIV Infection for Medicare Advantage members (Retroactively Effective to June 18, 2025) | | | | | | 9/8/2025 | | | |
| Updated Policies | Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies | MA07.017g | | 6/16/2025 | | | 9/9/2025 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | 9/9/2025 | |
| Updated Policies | Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic Studies | MA07.050m | | 9/22/2025 | | | 9/22/2025 | Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Intraoperative Neurophysiological Monitoring (INM) | MA07.051j | | 9/22/2025 | | | 9/22/2025 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Daratumumab (Darzalex®), Daratumumab and Hyaluronidase-fihj (Darzalex Faspro®) | MA08.079m | | 9/22/2025 | | | 9/22/2025 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Medicare Part B vs. Part D Crossover Drugs | MA08.007as | | 9/22/2025 | | | 9/22/2025 | Medical Coding | | |
| Updated Policies | Ground Ambulance Transport Services (Emergency and Nonemergency) | MA12.002e | | 9/22/2025 | | | 9/22/2025 | Medical Necessity Criteria | | |
| Updated Policies | Transcatheter Cardiac Valve Procedures | MA11.027g | | 7/2/2025 | | | 9/22/2025 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Off-label Coverage for Prescription Drugs and/or Biologics | MA08.012d | | 9/22/2025 | | | 9/22/2025 | Medical Necessity Criteria | | |
| Reissue Policies | Auricular Prostheses | MA05.068 | | 5/20/2024 | 9/3/2025 | | 9/3/2025 | | | |
| Reissue Policies | Air Ambulance Services | MA12.007b | | 1/1/2024 | 9/3/2025 | | 9/3/2025 | | | |
| Reissue Policies | Selective Photothermolysis Using Pulsed-Dye Lasers (PDL) | MA11.071b | | 7/11/2022 | 9/3/2025 | | 9/3/2025 | | | |
| Reissue Policies | Upper-Limb Prostheses | MA05.057d | | 4/1/2025 | 9/3/2025 | | 9/3/2025 | | | |
| Reissue Policies | Otoplasty or Non-Surgical External Ear Molding | MA11.058a | | 1/1/2024 | 9/3/2025 | | 9/3/2025 | | | |
| Reissue Policies | Abatacept (Orencia®) for Injection for Intravenous Use | MA08.028j | | 9/23/2024 | 9/3/2025 | | 9/3/2025 | | | |
| Reissue Policies | Sebelipase alfa (Kanuma®) | MA08.078e | | 1/1/2024 | 9/3/2025 | | 9/3/2025 | | | |
| Reissue Policies | Lifileucel (Amtagvi™) | MA08.172 | | 10/21/2024 | 9/3/2025 | | 9/3/2025 | | | |
| Reissue Policies | Direct Endoscopic Necrosectomy (DEN) for the Treatment of Pancreatic Necrosis | MA11.115 | | 1/20/2025 | 9/3/2025 | | 9/3/2025 | | | |
| Reissue Policies | Catheter Ablation of Cardiac Arrhythmias | MA11.060h | | 12/31/2024 | 9/3/2025 | | 9/3/2025 | | | |
| Reissue Policies | Fecal Microbiota Transplantation (FMT) | MA07.006d | | 7/1/2023 | 5/28/2025 | | 9/9/2025 | | | 9/9/2025 |
| Reissue Policies | Neuropsychological Testing for Neurologically Based Conditions | MA07.038k | | 10/1/2023 | 7/9/2025 | | 9/9/2025 | | | 9/9/2025 |
| Reissue Policies | Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions | MA11.087c | | 1/1/2024 | 7/9/2025 | | 9/9/2025 | | | 9/9/2025 |
| Reissue Policies | Serodiagnosis of Inflammatory Bowel Disease (IBD) and the Prometheus® IBD sgi Diagnostic™ Test | MA06.013e | | 1/1/2024 | 7/9/2025 | | 9/9/2025 | | | 9/9/2025 |
| Reissue Policies | Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD) | MA11.055f | | 1/2/2023 | 7/9/2025 | | 9/9/2025 | | | 9/9/2025 |
| Reissue Policies | Computer-Assisted Musculoskeletal Surgical Navigational Orthopedic Procedure | MA11.088c | | 1/1/2024 | 7/9/2025 | | 9/9/2025 | | | 9/9/2025 |
| Reissue Policies | Composite Tissue Allotransplantation of the Hand(s) and Face | MA11.112 | | 1/1/2024 | 8/6/2025 | | 9/9/2025 | | | 9/9/2025 |
| Reissue Policies | Fecal Microbiota Transplantation (FMT) | MA07.006d | | 7/1/2023 | 5/28/2025 | | 9/15/2025 | | | |
| Reissue Policies | Neuropsychological Testing for Neurologically Based Conditions | MA07.038k | | 10/1/2023 | 7/9/2025 | | 9/15/2025 | | | |
| Reissue Policies | Apheresis Therapy | MA06.001f | | 3/17/2025 | 7/9/2025 | | 9/15/2025 | | | 9/15/2025 |
| Reissue Policies | Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions | MA11.087c | | 1/1/2024 | 7/9/2025 | | 9/15/2025 | | | |
| Archived Policies | Laboratory-Based Vestibular Function Testing | MA07.031b | 9/5/2025 9:00 AM | 10/6/2025 | | | 9/5/2025 | | | |
| Archived Policies | Smell and Taste Dysfunction Testing | MA07.043a | 9/5/2025 9:00 AM | 10/6/2025 | | | 9/5/2025 | | | |
